Clinical Trials Logo

Healthy Male Subjects clinical trials

View clinical trials related to Healthy Male Subjects.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05559554 Not yet recruiting - Clinical trials for Healthy Male Subjects

A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects

Start date: October 26, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetic similarity of AK104 with different manufacturing process in healthy male subjects. Another purpose is to determine safety, and immunogenicity of AK104 with different manufacturing process.

NCT ID: NCT05478109 Not yet recruiting - Clinical trials for Healthy Male Subjects

A Clinical Trial of XZP-3287 for Material Balance

Start date: August 2, 2022
Phase: Phase 1
Study type: Interventional

A single-centre, open-label, mass balance and biotransformation study in healthy male subjects utilising a single oral dose of [14C] XZP-3287

NCT ID: NCT02614352 Not yet recruiting - Clinical trials for Healthy Male Subjects

Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

Start date: n/a
Phase: Phase 1
Study type: Interventional

Primary object : Evaluate pharmacokinetic property AG1502 and Candesartan 32mg and Atorvastatin 40mg in healthy male subjects.

NCT ID: NCT01928563 Not yet recruiting - Clinical trials for Healthy Male Subjects

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine

Start date: September 2013
Phase: Phase 1
Study type: Interventional

This study is designed to investigate the pharmacokinetic drug interaction between Udenafil and Dapoxetine in healthy male subjects Design : Randomized, open-label, 3-treatment, 6-sequence, 3-period crossover study Investigational Product : Udenafil, Dapoxetine

NCT ID: NCT01882296 Not yet recruiting - Clinical trials for Healthy Male Subjects

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

AGSPT_PD
Start date: n/a
Phase: Phase 1
Study type: Interventional

Primary object: Evaluate Pharmacodynamic property and safety administered S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in healthy male subjects Secondary object : Evaluate Dose-response of S-pantoprazole and pantoprazole and compare each dose-response

NCT ID: NCT01821521 Not yet recruiting - Clinical trials for Healthy Male Subjects

Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects

S-Pantoprazole
Start date: June 2013
Phase: Phase 1
Study type: Interventional

Primary object : Evaluate pharmacokinetic property administered S-pantoprazole 20mg and Pantoprazole 40mg in healthy male subjects Secondary object : Evaluate safety administered S-pantoprazole 20mg and Pantoprazole 40mg in healthy male subjects